Results 41 to 50 of about 267,865 (313)

Genetic basis of index patients with familial hypercholesterolemia in Chinese population: mutation spectrum and genotype-phenotype correlation

Lipids in Health and Disease, 2018
Background Although there have been many reports in the genetics of familial hypercholesterolemia (FH) worldwide, studies in regard of Chinese population are lacking.
Di Sun, Bing-Yang Zhou, Sha Li, Ning-Ling Sun, Qi Hua, Shu-Lin Wu, Yun-Shan Cao, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Ying Gao, Chuan-Jue Cui, Geng Liu, Jian-Jun Li   +13 more
doaj   +1 more source

Novel findings in relation to multiple anti-atherosclerotic effects of XueZhiKang in humans

Chronic Diseases and Translational Medicine, 2018
Background: Previous studies have clearly demonstrated that XueZhiKang (XZK), an extract of cholestin, can decrease low-density lipoprotein cholesterol (LDL-C) and cardiovascular events. However, the mechanism of the effects of XZK on atherosclerosis (AS)
Rui-Xia Xu, Yan Zhang, Yuan-Lin Guo, Chun-Yan Ma, Yu-Hong Yao, Sha Li, Xiao-Lin Li, Ping Qing, Ying Gao, Na-Qiong Wu, Cheng-Gang Zhu, Geng Liu, Qian Dong, Jing Sun, Jian-Jun Li   +14 more
doaj   +1 more source

The association of body mass index and its interaction with family history of dyslipidemia towards dyslipidemia in patients with type 2 diabetes: a cross-sectional study in Zhejiang Province, China

Frontiers in Public Health, 2023
ObjectivesThis study aimed to investigate the association between body mass index (BMI) and dyslipidemia and to explore the interaction between BMI and family history of dyslipidemia towards dyslipidemia in patients with type 2 diabetes.MethodsThis cross-
Xiang-Yu Chen, Le Fang, Jie Zhang, Jie-Ming Zhong, Jing-Jing Lin, Feng Lu   +5 more
doaj   +1 more source

Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study

Kidney & Blood Pressure Research, 2023
Introduction: Immunoglobulin A nephropathy (IgAN) is one of the most common glomerulonephritic diseases in the world. Several lines of evidence have suggested that dyslipidemia is related to the disease progression and prognosis of IgAN.
Sidi Liu, Zhenzhen Lu, Zhike Fu, Huijie Li, Chuying Gui, Yueyi Deng   +5 more
doaj   +1 more source

Intensive genetic analysis for Chinese patients with very high triglyceride levels: Relations of mutations to triglyceride levels and acute pancreatitisResearch in context

EBioMedicine, 2018
Background: Severe hypertriglyceridemia (SHTG, TG ≥5·65 mmol/L), a disease, usually resulting from a combination of genetic and environmental factors, may increase the risk of acute pancreatitis (AP).
Jing-Lu Jin, Di Sun, Ye-Xuan Cao, Hui-Wen Zhang, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Ying Gao, Qiu-Ting Dong, Geng Liu, Qian Dong, Jian-Jun Li   +11 more
doaj   +1 more source

Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1/2 pathway

Cardiovascular Diabetology, 2019
Background Reverse cholesterol transport (RCT) is an important cardioprotective mechanism and the decrease in cholesterol efflux can result in the dyslipidemia.
Ya-Ru Wu, Xiao-Yun Shi, Chun-Yan Ma, Yue Zhang, Rui-Xia Xu, Jian-Jun Li   +5 more
doaj   +1 more source

Dietary inflammation index is associated with dyslipidemia: evidence from national health and nutrition examination survey, 1999–2019

Lipids in Health and Disease, 2023
Background and aims This study aimed to investigate the association between the Dietary Inflammatory Index (DII) and dyslipidemia, as well as to evaluate the mortality risk associated with DII in participants with dyslipidemia.
Xiaozhe Chen, Chunlei Hou, Lei Yao, Jianhua Li, Mingtai Gui, Mingzhu Wang, Xunjie Zhou, Bo Lu, Deyu Fu   +8 more
doaj   +1 more source

Association between Dyslipidemia and Residual Renal Function in Patients on Chronic Peritoneal Dialysis

, 2011
Back ground: Dyslipidemia and residual renal function (RRF) have a significant impact on the cardiovascular mortality in dialysis patients, but their association in patients on chronic peritoneal dialysis (PD) has not been completely Studied.
CHEN, HUNG-YUAN;KAO, TZE-WAH;HUANG, JENQ-WEN;TSAI, TUN-JUN;WU, KWAN-DUN, 陳泓源;高芷華;黃政文;蔡敦仁;吳寬墩   +1 more
core   +1 more source

Dyslipidemia [PDF]

, 2019
Dyslipidemia is a major risk factor for cardiovascular disease, which is the leading cause of morbidity and mortality around the globe, particularly among aging populations.

core   +1 more source

Update on Dyslipidemia [PDF]

The Journal of Clinical Endocrinology & Metabolism, 2007
Recently, considerable progress has been made in understanding the genetic basis of dyslipidemias and in studying the safety and efficacy of lipid-lowering drugs for coronary heart disease (CHD) prevention. Novel loci have been identified for monogenic hypercholesterolemia, such as low-density lipoprotein (LDL) receptor (LDLR)-associated protein ...
Abhimanyu, Garg, Vinaya, Simha
openaire   +2 more sources